Telcon Inc (KQ:200230) — Market Cap & Net Worth
Market Cap & Net Worth: Telcon Inc (200230)
Telcon Inc (KQ:200230) has a market capitalization of $105.17 Million (₩155.19 Billion) as of August 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #18942 globally and #874 in its home market, demonstrating a 3.33% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Telcon Inc's stock price ₩2170.00 by its total outstanding shares 71513985 (71.51 Million). See Telcon Inc (200230) reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Telcon Inc Market Cap History: 2015 to 2026
Telcon Inc's market capitalization history from 2015 to 2026. Data shows growth from $59.13 Million to $105.17 Million (10.51% CAGR).
Index Memberships
Telcon Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$202.56 Billion | 0.05% | #338 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$202.56 Billion | 0.05% | #338 of 1384 |
Weight: Telcon Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Telcon Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Telcon Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Telcon Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $207.18 Million | $29.84 Billion | -$3.44 Billion | 0.01x | N/A |
| 2017 | $722.11 Million | $41.15 Billion | -$16.44 Billion | 0.02x | N/A |
| 2018 | $401.28 Million | $57.71 Billion | -$13.75 Billion | 0.01x | N/A |
| 2019 | $235.54 Million | $56.59 Billion | -$52.65 Billion | 0.00x | N/A |
| 2020 | $293.69 Million | $33.14 Billion | -$43.05 Billion | 0.01x | N/A |
| 2021 | $141.76 Million | $37.84 Billion | -$23.10 Billion | 0.00x | N/A |
| 2022 | $49.19 Million | $27.83 Billion | -$42.08 Billion | 0.00x | N/A |
| 2023 | $42.31 Million | $36.31 Billion | $13.91 Billion | 0.00x | 0.00x |
| 2024 | $284.48 Million | $37.87 Billion | -$26.32 Billion | 0.01x | N/A |
| 2025 | $44.44 Million | $43.16 Billion | -$11.46 Billion | 0.00x | N/A |
Competitor Companies of 200230 by Market Capitalization
Companies near Telcon Inc in the global market cap rankings as of August 4, 2026.
Key companies related to Telcon Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #503 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #528 globally with a market cap of $50.48 Billion USD ( CN¥344.98 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #550 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #503 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #528 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.48 Billion | CN¥54.08 |
| #550 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.60 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.80 |
Telcon Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Telcon Inc's market cap moved from $59.13 Million to $ 105.17 Million, with a yearly change of 10.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩105.17 Million | +136.64% |
| 2025 | ₩44.44 Million | -84.38% |
| 2024 | ₩284.48 Million | +572.39% |
| 2023 | ₩42.31 Million | -13.99% |
| 2022 | ₩49.19 Million | -65.30% |
| 2021 | ₩141.76 Million | -51.73% |
| 2020 | ₩293.69 Million | +24.69% |
| 2019 | ₩235.54 Million | -41.30% |
| 2018 | ₩401.28 Million | -44.43% |
| 2017 | ₩722.11 Million | +248.54% |
| 2016 | ₩207.18 Million | +250.41% |
| 2015 | ₩59.13 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Telcon Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $105.17 Million USD |
| MoneyControl | $105.17 Million USD |
| MarketWatch | $105.17 Million USD |
| marketcap.company | $105.17 Million USD |
| Reuters | $105.17 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Telcon Inc
TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea.